<DOC>
	<DOCNO>NCT01326403</DOCNO>
	<brief_summary>This randomize controlled trial comparing use tranexamic acid placebo patient admit hospital hip fracture .</brief_summary>
	<brief_title>Tranexamic Acid Hip Fracture Patients</brief_title>
	<detailed_description>1. transfusion allogeneic RBC 's free adverse event associate increase risk postoperative infection 2 . Tranexamic acid trauma patient show reduce 30-day mortality . Hospital trauma protocol include tranexamic acid patient major bleed . 3 . Tranexamic acid orthopedic elective joint reconstruction surgery show substantially decrease bleed knee hip arthroplasty . 4. hip fracture surgery , transexamic acid reduces erythrocyte transfusion rate may promote hypercoagulable state . 5 . Tranexamic acid antifibrinolytic drug inhibits plasminogen turn plasmin thereby inhibit clot breakdown .</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<mesh_term>Fractures , Closed</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients admit emergency room proximal hip fracture ( 31A31B accord Muller AO classification fracture long bone ) . Patients mentally capable give informed consent . 1 . Vascular event within last 2 month CVA , TIA , ACS , MI , DVT arterial thrombosis . 2 . Patients receive anticoagulation therapy Coumadin Plavix . 3 . Pregnancy breastfeed female . 4 . Previous arterial venous thrombosis 5 . History seizure . 6 . Creatinine &gt; 2 . 7 . Oestroprogestive therapy . 8 . Multiple fracture .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>proximal</keyword>
	<keyword>hip</keyword>
	<keyword>fracture</keyword>
</DOC>